In this review paper, we discuss the clinical utility of total insulin-like growth factor-I (IGF I) and that of IGF binding protein-3 (IGFBP-3).IGF-I and IGFBP-3 are well known to be dependent on GH and are thought to be useful in the
No takes yet. Share an insight, caveat, or question.
Hasegawa et al. (1995) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: